Robotic-assisted surgery for rectal adenocarcinoma: Short-term and midterm outcomes from 200 consecutive cases at a single institution

Masayasu Hara, Kevin Sng, Byung Eun Yoo, Jae Won Shin, Dong Won Lee, Seon Hahn Kim

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

BACKGROUND: Although robotic surgery is increasingly used in the management of rectal cancer, its oncologic safety remains uncertain. OBJECTIVE: We aimed to evaluate the feasibility and safety of robotic-assisted rectal cancer resection in terms of short-term and midterm outcomes. DESIGN: A prospectively collected set of samples was retrospectively evaluated. SETTINGS: Data included in this study were collected at a single institution from 2007 to 2011. PATIENTS: The study included 200 consecutive rectal cancer patients. INTERVENTION: The patients underwent robotic-assisted resection surgery performed by a single surgeon. MAIN OUTCOME MEASURES: The short-term (surgical outcome and pathologic data) and midterm outcomes (local pelvic control and overall and disease-free survival) were evaluated and compared with those in the published literature. RESULTS: The median patient age was 60 years, and the male:female ratio was 2:1. The median distance of rectal tumors from the anal verge was 6 cm. Preoperative radiotherapy was performed in 55 patients. The median operation time was 270 minutes, and the median blood loss was 190 mL. Grade 3 to 5 complications, according to the Clavien-Dindo classification, were observed in 15 patients (7.5%). The circumferential resection margin was positive in 5 patients (2.5%). During the median follow-up period of 29.8 months, recurrence occurred in 27 patients (distant metastasis, 18 patients; local recurrence, 7 patients; and both local recurrence and distant metastases, 2 patients). The local pelvic control and overall and disease-free survival rates of stage III patients at 5 years were 93.0%, 88.6%, and 76.6%. LIMITATIONS: This was a retrospective, uncontrolled study of selected patients by a single surgeon. CONCLUSIONS: Our results demonstrated an acceptable morbidity and a low rate of positive circumferential resection margin with effective local control. We also achieved excellent survival data. The midterm oncologic safety justifies the practice of robotic rectal cancer resection to further investigate its role on long-term outcomes.

Original languageEnglish
Pages (from-to)570-577
Number of pages8
JournalDiseases of the Colon and Rectum
Volume57
Issue number5
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Robotics
Adenocarcinoma
Rectal Neoplasms
Safety
Recurrence
Disease-Free Survival
Neoplasm Metastasis
Radiotherapy
Survival Rate
Retrospective Studies
Morbidity

Keywords

  • Rectal cancer
  • Rectal surgery
  • Robotics

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Robotic-assisted surgery for rectal adenocarcinoma : Short-term and midterm outcomes from 200 consecutive cases at a single institution. / Hara, Masayasu; Sng, Kevin; Yoo, Byung Eun; Shin, Jae Won; Lee, Dong Won; Kim, Seon Hahn.

In: Diseases of the Colon and Rectum, Vol. 57, No. 5, 01.01.2014, p. 570-577.

Research output: Contribution to journalArticle

Hara, Masayasu ; Sng, Kevin ; Yoo, Byung Eun ; Shin, Jae Won ; Lee, Dong Won ; Kim, Seon Hahn. / Robotic-assisted surgery for rectal adenocarcinoma : Short-term and midterm outcomes from 200 consecutive cases at a single institution. In: Diseases of the Colon and Rectum. 2014 ; Vol. 57, No. 5. pp. 570-577.
@article{3beaeb791b8c4f6091089ae8fbacabda,
title = "Robotic-assisted surgery for rectal adenocarcinoma: Short-term and midterm outcomes from 200 consecutive cases at a single institution",
abstract = "BACKGROUND: Although robotic surgery is increasingly used in the management of rectal cancer, its oncologic safety remains uncertain. OBJECTIVE: We aimed to evaluate the feasibility and safety of robotic-assisted rectal cancer resection in terms of short-term and midterm outcomes. DESIGN: A prospectively collected set of samples was retrospectively evaluated. SETTINGS: Data included in this study were collected at a single institution from 2007 to 2011. PATIENTS: The study included 200 consecutive rectal cancer patients. INTERVENTION: The patients underwent robotic-assisted resection surgery performed by a single surgeon. MAIN OUTCOME MEASURES: The short-term (surgical outcome and pathologic data) and midterm outcomes (local pelvic control and overall and disease-free survival) were evaluated and compared with those in the published literature. RESULTS: The median patient age was 60 years, and the male:female ratio was 2:1. The median distance of rectal tumors from the anal verge was 6 cm. Preoperative radiotherapy was performed in 55 patients. The median operation time was 270 minutes, and the median blood loss was 190 mL. Grade 3 to 5 complications, according to the Clavien-Dindo classification, were observed in 15 patients (7.5{\%}). The circumferential resection margin was positive in 5 patients (2.5{\%}). During the median follow-up period of 29.8 months, recurrence occurred in 27 patients (distant metastasis, 18 patients; local recurrence, 7 patients; and both local recurrence and distant metastases, 2 patients). The local pelvic control and overall and disease-free survival rates of stage III patients at 5 years were 93.0{\%}, 88.6{\%}, and 76.6{\%}. LIMITATIONS: This was a retrospective, uncontrolled study of selected patients by a single surgeon. CONCLUSIONS: Our results demonstrated an acceptable morbidity and a low rate of positive circumferential resection margin with effective local control. We also achieved excellent survival data. The midterm oncologic safety justifies the practice of robotic rectal cancer resection to further investigate its role on long-term outcomes.",
keywords = "Rectal cancer, Rectal surgery, Robotics",
author = "Masayasu Hara and Kevin Sng and Yoo, {Byung Eun} and Shin, {Jae Won} and Lee, {Dong Won} and Kim, {Seon Hahn}",
year = "2014",
month = "1",
day = "1",
doi = "10.1097/DCR.0000000000000088",
language = "English",
volume = "57",
pages = "570--577",
journal = "Diseases of the Colon and Rectum",
issn = "0012-3706",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Robotic-assisted surgery for rectal adenocarcinoma

T2 - Short-term and midterm outcomes from 200 consecutive cases at a single institution

AU - Hara, Masayasu

AU - Sng, Kevin

AU - Yoo, Byung Eun

AU - Shin, Jae Won

AU - Lee, Dong Won

AU - Kim, Seon Hahn

PY - 2014/1/1

Y1 - 2014/1/1

N2 - BACKGROUND: Although robotic surgery is increasingly used in the management of rectal cancer, its oncologic safety remains uncertain. OBJECTIVE: We aimed to evaluate the feasibility and safety of robotic-assisted rectal cancer resection in terms of short-term and midterm outcomes. DESIGN: A prospectively collected set of samples was retrospectively evaluated. SETTINGS: Data included in this study were collected at a single institution from 2007 to 2011. PATIENTS: The study included 200 consecutive rectal cancer patients. INTERVENTION: The patients underwent robotic-assisted resection surgery performed by a single surgeon. MAIN OUTCOME MEASURES: The short-term (surgical outcome and pathologic data) and midterm outcomes (local pelvic control and overall and disease-free survival) were evaluated and compared with those in the published literature. RESULTS: The median patient age was 60 years, and the male:female ratio was 2:1. The median distance of rectal tumors from the anal verge was 6 cm. Preoperative radiotherapy was performed in 55 patients. The median operation time was 270 minutes, and the median blood loss was 190 mL. Grade 3 to 5 complications, according to the Clavien-Dindo classification, were observed in 15 patients (7.5%). The circumferential resection margin was positive in 5 patients (2.5%). During the median follow-up period of 29.8 months, recurrence occurred in 27 patients (distant metastasis, 18 patients; local recurrence, 7 patients; and both local recurrence and distant metastases, 2 patients). The local pelvic control and overall and disease-free survival rates of stage III patients at 5 years were 93.0%, 88.6%, and 76.6%. LIMITATIONS: This was a retrospective, uncontrolled study of selected patients by a single surgeon. CONCLUSIONS: Our results demonstrated an acceptable morbidity and a low rate of positive circumferential resection margin with effective local control. We also achieved excellent survival data. The midterm oncologic safety justifies the practice of robotic rectal cancer resection to further investigate its role on long-term outcomes.

AB - BACKGROUND: Although robotic surgery is increasingly used in the management of rectal cancer, its oncologic safety remains uncertain. OBJECTIVE: We aimed to evaluate the feasibility and safety of robotic-assisted rectal cancer resection in terms of short-term and midterm outcomes. DESIGN: A prospectively collected set of samples was retrospectively evaluated. SETTINGS: Data included in this study were collected at a single institution from 2007 to 2011. PATIENTS: The study included 200 consecutive rectal cancer patients. INTERVENTION: The patients underwent robotic-assisted resection surgery performed by a single surgeon. MAIN OUTCOME MEASURES: The short-term (surgical outcome and pathologic data) and midterm outcomes (local pelvic control and overall and disease-free survival) were evaluated and compared with those in the published literature. RESULTS: The median patient age was 60 years, and the male:female ratio was 2:1. The median distance of rectal tumors from the anal verge was 6 cm. Preoperative radiotherapy was performed in 55 patients. The median operation time was 270 minutes, and the median blood loss was 190 mL. Grade 3 to 5 complications, according to the Clavien-Dindo classification, were observed in 15 patients (7.5%). The circumferential resection margin was positive in 5 patients (2.5%). During the median follow-up period of 29.8 months, recurrence occurred in 27 patients (distant metastasis, 18 patients; local recurrence, 7 patients; and both local recurrence and distant metastases, 2 patients). The local pelvic control and overall and disease-free survival rates of stage III patients at 5 years were 93.0%, 88.6%, and 76.6%. LIMITATIONS: This was a retrospective, uncontrolled study of selected patients by a single surgeon. CONCLUSIONS: Our results demonstrated an acceptable morbidity and a low rate of positive circumferential resection margin with effective local control. We also achieved excellent survival data. The midterm oncologic safety justifies the practice of robotic rectal cancer resection to further investigate its role on long-term outcomes.

KW - Rectal cancer

KW - Rectal surgery

KW - Robotics

UR - http://www.scopus.com/inward/record.url?scp=84901983598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901983598&partnerID=8YFLogxK

U2 - 10.1097/DCR.0000000000000088

DO - 10.1097/DCR.0000000000000088

M3 - Article

C2 - 24819096

AN - SCOPUS:84901983598

VL - 57

SP - 570

EP - 577

JO - Diseases of the Colon and Rectum

JF - Diseases of the Colon and Rectum

SN - 0012-3706

IS - 5

ER -